Cole and Jaenisch explain why defending against AI poisoning in pharma manufacturing calls for a data steward role, immutable instruction ledgers, and automation.
|Articles|November 2, 2022
- Pharmaceutical Technology, November 2022
- Volume 46
- Issue 11
- Pages: 12
3000-Gallon Multi-Shaft Mixers
Author(s)Pharmaceutical Technology Editors
The ROSS VersaMix Multi-Shaft Mixers are designed for processing medium-to-high viscosity applications up to several hundred thousand centipoise.
ROSS VersaMix Multi-Shaft Mixers are designed for processing medium-to-high viscosity applications up to several hundred thousand centipoise; this includes thick slurries, pastes, gels, and suspensions. Pictured are the 3000-gallon VersaMix Model VM-3000 equipped with a custom combination of three agitators, each driven by a 60 HP TEFC inverter-duty motor. The three-wing anchor and two screw augers are independently controlled with variable speeds for efficient batch turnover at every ingredient addition and mixing stage.
These vacuum-rated VMC-3000’s are operated from an independent touchscreen control panel. The mixers also feature stainless-steel type 304 dimpled, dual-zone jackets, which are designed for 100 psig at 200°F. VersaMix models range from laboratory- to large-scale capacities of up to 4000 gallons.
Articles in this issue
about 4 years ago
Streamlining Equipment Quality and Flexibilityabout 4 years ago
Novel Formulations and Line Extensions with Soft Capsule Technologyabout 4 years ago
Excipients for Solubility Enhancement of Parenteral Formulationsabout 4 years ago
Putting a Spotlight on Particle Engineeringabout 4 years ago
Examining Trends in Oral Solid Dosage Manufacturingabout 4 years ago
Updated Guidance to the European Data Governance Actabout 4 years ago
Trial Declineabout 4 years ago
Addressing the Key Pitfalls Hindering Technology Transfer SuccessRelated to this article
Terry Katz, CEO and co-founder of ForgeStop Technology Corporation, explains how the company’s product is worth the investment by protecting products and patients.
Terry Katz, CEO and co-founder of ForgeStop Technology Corporation, explains how its connected technology can enhance anticounterfeiting and how data are handled within the product.
Celtic Renewables won the CPHI Award for Sustainable Pharma Excellence for its green chemicals used in pharmaceutical manufacturing. Bettina Brierley, chief commercial officer, talks about the adoption, capacity, and pricing of biosolvents.
Terry Katz, CEO and cofounder of ForgeStop Technology Corporation, explains the company’s CPHI Award-winning connected product technology and how it helps to combat drug counterfeiting.
Bettina Brierley, chief commercial officer at Celtic Renewables, discusses commercialization of biosolvents for pharmaceutical manufacturing.
Coverage from AAPS PharmSci 360 and CPHI Milan featured discussion about impurities, devices, and supply resilience. This week also included topics such as AI accountability, oral peptides, and new licensing deals.
CDMOs, OEMs, and Used Equipment Resellers are Joining Forces to Onshore Pharmaceutical Manufacturing
Onshoring pharmaceutical manufacturing can be made more practical by collaborating with CDMOs that have gray space, supported by strong relationships with used equipment dealers and OEMs.
Trending on Pharmaceutical Technology
1
Signs Point to FDA Shelving Priority Voucher Pilot, Stalling Fast-Track Drug Reviews
2
The Impact of Excipients on Continuous Manufacturing and the Risk of Nitrites
3
PharmTech AI Pulse Check: Who's Accountable When a Vendor's AI Model Changes?
4
France Remains One of Europe’s Leading Biotech Funding Hubs
5